EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study

Floran Begue, Kévin Chemello, Bryan Veeren iD, Brice Lortat-Jacob iD, Alexy Tran-Dinh, Nathalie Zappella, Aurelie Snauwaert, Tiphaine Robert, Philippe Rondeau iD, Marie Lagrange-Xelot, Philippe Montravers iD, David Couret iD und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054605 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Floran Begue und 13 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, UMR 1188 Diabète Athérothrombose Réunion Océan Indien (DéTROI), Université de La Réunion, 97410 Saint-Pierre de La Réunion, France. Hauptthemen laut MEDLINE: Cholesterol, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conseil Régional de La Réunion, FEDER, BIOST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 infection goes beyond acute pneumonia, as it also impacts lipid metabolism. Decreased HDL-C and LDL-C levels have been reported in patients with COVID-19. The lipid profile is a less robust biochemical marker than apolipoproteins, components of lipoproteins. However, the association of apolipoprotein levels during COVID-19 is not well described and understood. The objective of our study is to measure plasma levels of 14 apolipoproteins in patients with COVID-19 and to evaluate the relationships between apolipoprotein levels, severity factors and patient outcomes. From November to March 2021, 44 patients were recruited on admission to the intensive care unit because of COVID-19. Fourteen apolipoproteins and LCAT were measured by LC-MS/MS in plasma of 44 COVID-19 patients on admission to the ICU and 44 healthy control subjects. Absolute apolipoprotein concentrations were compared between COVID-19 patients and controls. Plasma apolipoproteins (Apo) A (I, II, IV), C(I, II), D, H, J and M and LCAT were lower in COVID-19 patients, whereas Apo E was higher. COVID-19 severity factors such as PaO2/FiO2 ratio, SO-FA score and CRP were correlated with certain apolipoproteins. Lower Apo B100 and LCAT levels were observed in non-survivors of COVID-19 versus survivors. To conclude, in this study, lipid and apolipoprotein profiles are altered in COVID-19 patients. Low Apo B100 and LCAT levels may be predictive of non-survival in COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolCOVID-19HumansCohort StudiesChromatography, LiquidSARS-CoV-2Tandem Mass SpectrometryApolipoproteinsApolipoproteins AApolipoprotein B-100Intensive Care UnitsApolipoprotein A-IApolipoproteins BApolipoprotein A-II

Stichwörter der Autor:innen

COVID-19HDL-CICULDL-Capolipoproteininfectionmass spectrometryoutcome

Substanzen

CholesterolApolipoproteinsApolipoproteins AApolipoprotein B-100Apolipoprotein A-IApolipoproteins BApolipoprotein A-II

Autor:innen und Institutionen

  • INSERM, UMR 1188 Diabète Athérothrombose Réunion Océan Indien (DéTROI), Université de La Réunion, 97410 Saint-Pierre de La Réunion, France.
  • Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Anesthesiology and Critical Care Medicine, Assistance, Bichat-Claude Bernard Hospital, 75018 Paris, France.
  • UFR Denis Diderot, University of Paris, 75015 Paris, France.
  • Laboratory for Vascular Translational Science, French Institute of Health and Medical Research (INSERM) U1148, 75018 Paris, France.
  • Assistance Publique-Hôpitaux de Paris (AP-HP), Biochemistry Department, Bichat-Claude Bernard Hospital, 75018 Paris, France.
  • CHU de La Réunion, 97400 Saint-Denis, France.

ORCID-Profile: Bryan Veeren, Brice Lortat-Jacob, Philippe Rondeau, Philippe Montravers, David Couret, Sébastien Tanaka, Olivier Meilhac

Förderung

  • Conseil Régional de La Réunion
  • FEDER
  • BIOST
  • Région Réunion
  • BIOST Fédération

Zitieren

APA

Begue, F., Chemello, K., Veeren, B., Lortat-Jacob, B., Tran-Dinh, A., Zappella, N., Snauwaert, A., Robert, T., Rondeau, P., Lagrange-Xelot, M., Montravers, P., Couret, D., Tanaka, S., & Meilhac, O. (2023). Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054605

Vancouver

Begue F, Chemello K, Veeren B, Lortat-Jacob B, Tran-Dinh A, Zappella N, et al. Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054605

BibTeX
@article{Begue2023,
  author = {Begue, Floran and Chemello, Kévin and Veeren, Bryan and Lortat-Jacob, Brice and Tran-Dinh, Alexy and Zappella, Nathalie and Snauwaert, Aurelie and Robert, Tiphaine and Rondeau, Philippe and Lagrange-Xelot, Marie and Montravers, Philippe and Couret, David and Tanaka, Sébastien and Meilhac, Olivier},
  title = {Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054605}
}
Kostenlos starten →